Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
'Cough virus' kills liver cancer cells — and the hepatitis virus that causes them
A virus that causes childhood coughs and colds could help in the fight against primary liver cancer, according to a study.
Faulty molecule offers new target for treating liver cancer
Blocking a single faulty molecule in a biological process that drives the growth of advanced liver cancers could offer a new way to treat the disease, researchers have found.
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma
The Institute of Cancer Research, London, has issued the following statement from Professor Kevin Harrington in response to the decision by NICE to approve the use of talimogene laherparepvec (T-VEC) for treating inoperable metastatic melanoma in adults when systemically administered immunotherapies are not suitable.
Scientists identify genetic cause of myeloma bone disease
Scientists have identified a change in the DNA of patients with myeloma that increases their risk of developing bone disease, a common and serious complication of this cancer.
Imaging probe outperforms the best external detector for early cervical cancer
An endovaginal magnetic resonance imaging technique is more accurate at detecting early-stage cervical cancer than the best widely available method.
The ongoing battle with melanoma
Until recently there were no effective treatments for metastatic melanoma, but in the last decade we have seen a flurry of treatment breakthroughs, and scientists at the ICR have been at the heart of the fight against the disease.
New drugs could stop skin cancer from spreading
Two new drugs could stop melanoma from spreading to other parts of the body, a new study has found.
Trial of new ‘resistance-busting’ skin cancer drug begins as first patient receives treatment
The patient has received a new panRAF inhibitor – a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
Identical twins reveal new clues to origins of childhood leukaemia
A new study of identical twins with leukaemia has traced its earliest genetic changes all the way back to immature cells from the immune system, which develop before children are even born.
New clues to skin cancer development show sunscreen is not enough
Scientists have shown that sunscreen cannot be relied upon alone to prevent malignant melanoma, the most deadly form of skin cancer.
MicroRNA could be key target for bowel cancer treatment
A tiny genetic molecule called microRNA plays a central role in bowel cancer and could be key to developing new treatments for the disease, say ICR Researchers.
Mutations in leukaemia gene linked to new childhood growth disorder
Genetic mutations associated with leukaemia cause a newly described condition that affects growth and intellectual development in children.